Log in to save to my catalogue

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy f...

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy f...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e2f707e095284536bce857e525411146

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

About this item

Full title

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Publisher

England: BioMed Central Ltd

Journal title

Cost effectiveness and resource allocation, 2023-07, Vol.21 (1), p.46-46, Article 46

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Stereotactic body radiotherapy (SBRT) is a novel radio-therapeutic technique that has recently emerged as standard-of-care treatment for medically inoperable, early-stage non-small cell lung cancer (NSCLC). In this study, we compared the cost-effectiveness of SBRT with that of conventional fractionated radiotherapy (CFRT) in patients with medically...

Alternative Titles

Full title

Cost-effectiveness of stereotactic body radiotherapy versus conventional fractionated radiotherapy for medically inoperable, early-stage non-small cell lung cancer

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e2f707e095284536bce857e525411146

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e2f707e095284536bce857e525411146

Other Identifiers

ISSN

1478-7547

E-ISSN

1478-7547

DOI

10.1186/s12962-023-00452-w

How to access this item